Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PROMISE Trial: A PROspective Randomised Double-blind Parallel Group Placebo-controlled Multicentre Trial of Faecal MIcrobiota tranSplantation to Improve the Primary outcomE (First Hospitalisation Due to Infection) in Patients With Cirrhosis Over 24 Months

NCT06461208 is registered in ClinicalTrials.gov with King's College London as lead sponsor.

NCT NCT06461208
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06461208 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PROMISE Trial: A PROspective Randomised Double-blind Parallel Group Placebo-controlled Multicentre Trial of Faecal MIcrobiota tranSplantation to Improve the Primary outcomE (First Hospitalisation Due to Infection) in Patients With Cirrhosis Over 24 Months
Lead sponsor
King's College London
Phase
Phase 3
Overall status
Recruiting
Start date
June 21, 2023
Completion date
June 30, 2028
Enrollment
300 (estimated)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

liver cirrhosis